2006
DOI: 10.1074/jbc.m505869200
|View full text |Cite
|
Sign up to set email alerts
|

HIC-5 Is a Novel Repressor of Lymphoid Enhancer Factor/T-cell Factor-driven Transcription

Abstract: Activation of Wnt/␤-catenin target genes is regulated by a heterodimer of ␤-catenin and the high mobility group box transcription factors of the lymphoid enhancer factor (LEF)/T-cell factor (TCF) family. In vertebrates, four LEF/TCF family members have been identified. They all contain a conserved ␤-catenin-binding motif at the N terminus and a highly conserved high mobility group box for DNA binding. The core sequence between these motifs is less conserved and contributes to the specific properties of the ind… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
42
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(43 citation statements)
references
References 42 publications
1
42
0
Order By: Relevance
“…Interestingly, preliminary analyses of a tissue microarray [127] of breast cancer appear to mirror these findings, showing phospho-S250 immuno-reactivity to positively correlate with breast cancer invasiveness ( Figure 5.6 (B)). Additionally, these TMA results would suggest that the phospho-S250 immuno-reactivity is also not solely dependent on Her2 status.…”
Section: Paxillin S250 Is Differentially Phosphorylated In Breast Cancermentioning
confidence: 70%
See 1 more Smart Citation
“…Interestingly, preliminary analyses of a tissue microarray [127] of breast cancer appear to mirror these findings, showing phospho-S250 immuno-reactivity to positively correlate with breast cancer invasiveness ( Figure 5.6 (B)). Additionally, these TMA results would suggest that the phospho-S250 immuno-reactivity is also not solely dependent on Her2 status.…”
Section: Paxillin S250 Is Differentially Phosphorylated In Breast Cancermentioning
confidence: 70%
“…Paraffin-embedded human tissues (HuFPT130) and tissue microarrays (BRC961) [127] were purchased from US Biomax (Rockville, Maryland, USA). Tissues were processed as described by Luise and Nuciforo (2006) [128].…”
Section: 4-immunohistochemistrymentioning
confidence: 99%
“…In addition AmphiTcf includes a CRARF domain (amino acids 392-396) comparable to those of all known TCF/LEF proteins of invertebrates as well as Tcf1 and Tcf4 of vertebrates; this motif evidently both binds DNA and transactivates (Hecht and Stemmler, 2003). There is also a putative Groucho (Grg) binding domain (amino acids 212-241; exon VI), which is structurally similar to the Grg binding/ HIC-5 interaction site known for several splice variants of vertebrate TCF/LEF family members (Ghogomu et al, 2006). In contrast, AmphiTcf lacked counterparts for following motifs: the CAD domain of vertebrate Lef1, the CtBP domain of vertebrate Tcf3 and Tcf4, and the LVPQ and SXXSS domains of vertebrate Tcf3 (van Noort and Clevers, 2002;Liu et al, 2005).…”
Section: Sequence Of Amphitcf and Alignment With Related Genes: Phylomentioning
confidence: 92%
“…In the absence of Wnt signal Lef/Tcf acts as transcriptional repressors of Wnt target genes by forming a complex with several corepressors including myeloid translocation gene related-1 (Mtgr1) (Moore et al, 2008), corepressor of Pan (Coop) (Song et al, 2010), hydrogen peroxide-inducible clone (HIC5) (Ghogomu et al, 2006;Li et al, 2011) and the most intensively studied Groucho/transducin-like enhancer of split (Gro/TLE) repressor family Chen and Courey, 2000). Upon translocation of β-catenin to nucleus Lef/Tcf factors become converted into transcriptional activators and perform expression of the target genes (Daniels and Weis, 2005).…”
Section: Canonical Wnt Signalingmentioning
confidence: 99%